Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
Avacc 3 has significant advantages over existing whooping cough vaccines
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Subscribe To Our Newsletter & Stay Updated
